Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge
The RNA-dependent RNA polymerase (RdRp) is an essential enzyme for the viral replication process, catalyzing the viral RNA synthesis using a metal ion-dependent mechanism. In recent years, RdRp has emerged as an optimal target for the development of antiviral drugs, as demonstrated by recent approva...
Main Authors: | Francesca Picarazzi, Ilaria Vicenti, Francesco Saladini, Maurizio Zazzi, Mattia Mori |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/23/5695 |
Similar Items
-
Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus
by: Jie Yuan, et al.
Published: (2020-07-01) -
Monoclonal antibody against EV71 3Dpol inhibits the polymerase activity of RdRp and virus replication
by: Yaoming Li, et al.
Published: (2019-01-01) -
The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp
by: Arun Bahadur Gurung, et al.
Published: (2021-02-01) -
SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay System
by: Jung Sun Min, et al.
Published: (2021-08-01) -
RdRp mutations are associated with SARS-CoV-2 genome evolution
by: Doğa Eskier, et al.
Published: (2020-07-01)